BCR and chronic myelogenous leukemia, BCR-ABL1 positive: Additionally, the BCR::ABL fusion protein, which is central to CML pathogenesis, has been shown to mediate genomic instability through the activation of various DNA repair pathways, leading to further mutations and chromosomal aberrations [56].